Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 3 (2006), Issue 8 (August)

1. Regulation of sodium-glucose cotransporter SGLT1 in the intestine of hypertensive rats.
   Am J Physiol Regul Integr Comp Physiol, 291(3): R760-7. [Abstract] [Full-text]
2. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture).
   Am J Physiol Heart Circ Physiol, 291(3): H985-1002. [Abstract] [Full-text]
3. Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension.
   Am J Physiol Renal Physiol, 291(3): F612-8. [Abstract] [Full-text]
4. Metabolic and skeletal complications of HIV infection: the price of success.
   JAMA, 296(7): 844-54. [Abstract] [Full-text]
5. Potential side effects of renin inhibitors--mechanisms based on comparison with other renin-angiotensin blockers.
   Expert Opin Drug Saf, 5(5): 631-41. [Abstract] [Full-text]
6. Abnormal renovascular parathyroid hormone-1 receptor in hypertension: Primary defect or secondary to angiotensin ii type 1 receptor activation?
   Endocrinology, 147(9): 4384-91. [Abstract] [Full-text]
7. Acute reduction of blood pressure by nitroglycerin does not normalize large artery stiffness in essential hypertension.
   Hypertension, 48(3): 404-10. [Abstract] [Full-text]
8. Importance of the electrocardiographic strain pattern in patients with resistant hypertension.
   Hypertension, 48(3): 437-42. [Abstract] [Full-text]
9. Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension.
   Hypertension, 48(3): 397-403. [Abstract] [Full-text]
10. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
    Hypertension, 48(3): 374-84. [Abstract] [Full-text]
11. Mutation of the follicle-stimulating hormone receptor gene 5'-untranslated region associated with female hypertension.
    Hypertension, 48(3): 512-8. [Abstract] [Full-text]
12. Role of extracellular superoxide dismutase in hypertension.
    Hypertension, 48(3): 473-81. [Abstract] [Full-text]
13. The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy.
    Hypertension, 48(3): 385-91. [Abstract] [Full-text]
14. Prevention of hypertension and organ damage in 2-kidney, 1-clip rats by tetradecylthioacetic acid.
    Hypertension, 48(3): 460-6. [Abstract] [Full-text]
15. Remodeling of the cardiac pacemaker L-type calcium current and its beta-adrenergic responsiveness in hypertension after neuronal NO synthase gene transfer.
    Hypertension, 48(3): 443-52. [Abstract] [Full-text]
16. Development of hypertension and kidney hypertrophy in transgenic mice overexpressing ARAP1 gene in the kidney.
    Hypertension, 48(3): 453-9. [Abstract] [Full-text]
17. Survey of intensive care physicians on the recognition and management of intra-abdominal hypertension and abdominal compartment syndrome.
    Crit Care Med, 34(9): 2340-8. [Abstract] [Full-text]
18. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
    J Surg Res, 135(1): 38-44. [Abstract] [Full-text]
19. Nebivolol: new therapy update.
    Cardiol Rev, 14(5): 259-64. [Abstract] [Full-text]
20. Alcohol consumption and plasma atrial natriuretic peptide (from the HyperGEN study).
    Am J Cardiol, 98(5): 628-32. [Abstract] [Full-text]
21. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study.
    Brain, 129: 2375-83. [Abstract] [Full-text]
22. Different effects of angiotensin receptor blockade on end-organ damage in salt-dependent and salt-independent hypertension.
    Circulation, 114(9): 905-11. [Abstract] [Full-text]
23. Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension.
    Stroke, 37(9): 2381-4. [Abstract] [Full-text]

© 2004-2008 Hypertension Research Today. All Rights Reserved.